Nephrotoxicity of concomitant use of tacrolimus and teicoplanin in allogeneic hematopoietic stem cell transplant recipients

T. Mori, T. Shimizu, J. Kato, T. Kikuchi, Sumiko Kohashi, Y. Koda, T. Toyama, M. Saburi, O. Iketani, S. Okamoto

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Both tacrolimus and glycopeptide antibiotics are known to be nephrotoxic, and are often concomitantly given after hematopoietic stem cell transplantation (HSCT) or solid organ transplantation. The aim of this study is to evaluate the nephrotoxicity of concomitant use of tacrolimus and glycopeptide antibiotics in HSCT recipients. We retrospectively evaluated 67 patients who received intravenous tacrolimus and teicoplanin concomitantly for >4 days after allogeneic HSCT for hematologic diseases. Therapeutic drug monitoring (TDM) was performed in all patients for both tacrolimus and teicoplanin. The median age of the patients was 48 years (range: 16-62), and the median duration of the co-administration of tacrolimus and teicoplanin was 11 days (range: 4-40). The mean serum creatinine (sCr) level tended to be elevated after the co-administration (from 0.69 ± 0.26 to 0.75 ± 0.30 mg/dL; P = 0.08); however, a 2-fold or greater increase in sCr was observed only in 2 (3.0%) patients. Increased sCr was reversible, and no patient required hemodialysis. These results suggest that the incidence of clinically significant nephrotoxicity can be minimized if the TDM of each drug is properly applied.

Original languageEnglish
Pages (from-to)329-332
Number of pages4
JournalTransplant Infectious Disease
Volume16
Issue number2
DOIs
Publication statusPublished - 2014 Apr

Keywords

  • Nephrotoxicity
  • Serum creatinine
  • Tacrolimus
  • Teicoplanin
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Infectious Diseases
  • Transplantation

Fingerprint Dive into the research topics of 'Nephrotoxicity of concomitant use of tacrolimus and teicoplanin in allogeneic hematopoietic stem cell transplant recipients'. Together they form a unique fingerprint.

Cite this